These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31896943)

  • 1. Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sites.
    Moskovitz M; Jao K; Su J; Brown MC; Naik H; Eng L; Wang T; Kuo J; Leung Y; Xu W; Mittmann N; Moody L; Barbera L; Devins G; Li M; Howell D; Liu G
    Curr Oncol; 2019 Dec; 26(6):e733-e741. PubMed ID: 31896943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: a real-world cross-sectional study.
    Doherty MK; Leung Y; Su J; Naik H; Patel D; Eng L; Kong QQ; Mohsin F; Brown MC; Espin-Garcia O; Vennettilli A; Renouf DJ; Faluyi OO; Knox JJ; MacKay H; Wong R; Howell D; Mittmann N; Darling GE; Cella D; Xu W; Liu G
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29905764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
    Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis.
    O'Kane GM; Su J; Tse BC; Tam V; Tse T; Lu L; Borean M; Tam E; Labbé C; Naik H; Mittmann N; Doherty MK; Bradbury PA; Leighl NB; Shepherd FA; Richard NM; Edelstein K; Shultz D; Brown MC; Xu W; Howell D; Liu G
    Oncologist; 2019 Jul; 24(7):e501-e509. PubMed ID: 30952820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationships among common symptoms in the elderly and their effects on health-related quality of life: a cross-sectional study in rural Korea.
    Mun S; Park K; Baek Y; Lee S; Yoo JH
    Health Qual Life Outcomes; 2016 Oct; 14(1):146. PubMed ID: 27733204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the Edmonton Symptom Assessment System-Revised: Renal to the EQ-5D-5L in patients with chronic kidney disease.
    Wen J; Jin X; Al Sayah F; Short H; Ohinmaa A; Davison SN; Walsh M; Johnson JA
    Qual Life Res; 2022 Feb; 31(2):567-577. PubMed ID: 34278540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between EQ-5D and fatigue in a Dutch general population sample: an explorative study.
    Spronk I; Polinder S; Bonsel GJ; Janssen MF; Haagsma JA
    Health Qual Life Outcomes; 2021 Apr; 19(1):135. PubMed ID: 33926461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between malnutrition risk and revised Edmonton Symptom Assessment System (ESAS-r) scores in an adult outpatient oncology population: a cross-sectional study.
    McLay K; Stonewall N; Forbes L; Peters C
    J Patient Rep Outcomes; 2024 Jul; 8(1):71. PubMed ID: 38995461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Patients? Willingness to Routinely Complete the EQ-5D Instrument at Clinic Visits.
    Naik H; Qiu X; Brown MC; Mahler M; Hon H; Tiessen K; Thai H; Ho V; Gonos C; Charow R; Pat V; Irwin M; Herzog L; Ho A; Xu W; Howell D; Seung SJ; Liu G; Mittmann N
    J Popul Ther Clin Pharmacol; 2016 Sep; 23(3):e196-e204. PubMed ID: 27783475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Cohabitants Reliably Complete Questionnaires for Patients in a Terminal Cancer Stage when Assessing Quality of Life, Pain, Depression, and Anxiety?
    Groot OQ; Paulino Pereira NR; Bongers MER; Ogink PT; Newman ET; Verlaan JJ; Raskin KA; Lozano-Calderon SA; Schwab JH
    Clin Orthop Relat Res; 2021 Apr; 479(4):792-801. PubMed ID: 33165035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile Equating.
    Thompson NR; Lapin BR; Katzan IL
    Pharmacoeconomics; 2017 Nov; 35(11):1167-1176. PubMed ID: 28710740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Mapping Algorithms Based on Raw Scores Overestimate QALYs Gained by Treatment? A Comparison of Mappings Between the Roland-Morris Disability Questionnaire and the EQ-5D-3L Based on Raw and Differenced Score Data.
    Madan J; Khan KA; Petrou S; Lamb SE
    Pharmacoeconomics; 2017 May; 35(5):549-559. PubMed ID: 28063083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping.
    Gray LA; Wailoo AJ; Hernandez Alava M
    Value Health; 2018 Dec; 21(12):1399-1405. PubMed ID: 30502783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health.
    Crick K; Al Sayah F; Ohinmaa A; Johnson JA
    Qual Life Res; 2018 Jun; 27(6):1625-1633. PubMed ID: 29516342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Assessment of Health Utility Scores, Symptoms and Toxicities in Patients with Small Cell Lung Cancer Using Real World Data.
    Kuehne N; Hueniken K; Xu M; Shakik S; Vedadi A; Pinto D; Brown MC; Bradbury PA; Shepherd FA; Sacher AG; Leighl NB; Xu W; Lok BH; Liu G; O'Kane GM
    Clin Lung Cancer; 2022 Mar; 23(2):e154-e164. PubMed ID: 34688531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of pain in determining the health status of cancer patients with bone metastases: A secondary analysis of data from three Phase III registration trials.
    Mendoza TR; Dueck AC; Shi Q; Ma H; Zhang J; Qian Y; Cleeland CS
    Eur J Pain; 2018 Mar; 22(3):565-571. PubMed ID: 29082574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of depressive symptoms on health value in patients with gynecologic cancer: A comparison with physical symptoms and performance status.
    Yu YL; Yeo H; Kang S
    Gynecol Oncol; 2020 Jun; 157(3):733-739. PubMed ID: 32307127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).
    Cappelleri JC; Koduru V; Bienen EJ; Sadosky A
    Qual Life Res; 2017 Feb; 26(2):467-477. PubMed ID: 27485915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.